LAWRENCE, Mass., Feb. 23 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced that Elise A. Tordella has joined the Company as Vice President and General Manager of Critical Care Therapies. In this position, Ms. Tordella will oversee NxStage's strategic growth initiatives to provide quality continuous renal replacement therapy (CRRT) solutions to the estimated U.S. $100 million critical care market opportunity.
"I am excited to join NxStage and be a part of a company that is making significant contributions to the dialysis community, specifically critical care patients," said Elise Tordella. "I look forward to using my knowledge and experience in the medical device industry to help foster NxStage's continued growth in the critical care market and further enhance our value proposition to customers."
About NxStage Medical
Forward-Looking Statements
NxStage Medical, Inc.
